Intimation of closure of trading window
Awaiting price reaction for this filing.
MPS Pharmaa Limited (formerly Advik Laboratories) has informed BSE that its trading window will be closed for all directors, promoters, key managerial personnel, designated persons, employees, and their immediate relatives starting October 1, 2025. The window will remain shut until 48 hours after the company declares its unaudited financial results for the quarter and half-year ending September 30, 2025. The board meeting date to approve these results will be communicated to the exchange later. This is a routine compliance filing under SEBI's Insider Trading Regulations to prevent trading on unpublished price-sensitive information.
No direct impact on shareholders or stock price. This is a standard regulatory disclosure indicating that financial results are forthcoming, which investors should watch for as it may influence near-term price movement.